Medication
Injectable Naloxone Hydrochloride
DIN 02455935 · Omega Laboratories Limited
What it is
- Active ingredients
- Naloxone Hydrochloride — 0.4 mg
- Form and routes
- Solution · Intravenous, Intramuscular, Subcutaneous
- Schedule
- ETHICAL
- Authorised since
- 2016-08-05
Source: Health Canada — Drug Product Database. Data current as of 2026-08-12.
Products with the same active ingredient
- Naloxone HCL Injection - 0.4MG/ML Usp
- Naloxone Hydrochloride Injection Usp
- Naloxone Hydrochloride Injection
- S.o.s. Naloxone Hydrochloride Injection
- Naloxone Injectable
- Naloxone Hydrochloride Injection, Usp
- Naloxone Hydrochloride Injection Usp
Grouped by Health Canada’s active-ingredient group number. Products in a group do not always share a strength — check the strength above against your own. Sharing an active ingredient does not mean two products can be substituted for each other: whether a substitution is permitted is a provincial decision, and this page does not show it. Ask a pharmacist.
How it is classified
- Anatomical main group
- Various
- ATC code
- V03AB15
The Anatomical Therapeutic Chemical code records the body system a medicine acts on and its chemical grouping. It is not a statement of what this medication treats, and nothing on this page is. For the full classification of V03AB15, see the WHO ATC/DDD Index.
Recalls and safety alerts
Recall matching is not available yet.
RxMonitor does not yet match Health Canada recalls to individual products — that arrives in a later release. Nothing on this page should be read as confirming that this medication has not been recalled.
Search Health Canada recalls for Injectable Naloxone Hydrochloride →